Autopsy report · NCT02890888
Effect of Hyperbaric Oxygen on Functional Connectivity in Patients With Cerebral Small Vessel Disease
Cause of deathFunding or business, also staffing, sites or logistics
“Depletion of Funds and Illness of principal investigator”
Life of this trial
- Registered 2 months before it started.
- Ran for about 2 years 11 months before it stopped.
- 6 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- St. Luke's Hospital, Chesterfield, Missouri
- Sponsor type
- University, hospital or other
- Conditions
- Cerebral Small Vessel Diseases
- Interventions
- hyperbaric oxygen treatment
- Participants
- 6
- Sites
- 3
- Countries
- United States
Trials that died the same way
- Prevena Incision Management System Wound Care
“Principal Investigator left the Hospital and did not transfer the study” - Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy
“Retirement of the Principal Investigator” - Digital Therapeutic Lifestyle Intervention Program for Patients With MASLD
“Principal investigator left the institution and study was never funded” - Identification and Characterization of Molecular Markers in Musculoskeletal Tumors
“Principal Investigator has left the Institution” - FOLFIRINOX in Patients With Inoperable Pancreatic Cancer
“The principal investigator terminated the study due to inactivity and low enrollment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.